Wikidata

(Q44083616)

English

Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy.

scientific article published in August 2002

In more languages

Statements

title
Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12149193
retrieved
29 November 2017
main subject
thalidomide
0 references
doxorubicin
0 references
author name string
Eric Siegel
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12149193
retrieved
29 November 2017
Fariba Saghafifar
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12149193
retrieved
29 November 2017
Athanasios Fassas
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12149193
retrieved
29 November 2017
Christopher Morris
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
12149193
retrieved
29 November 2017
Louis Fink
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
12149193
retrieved
29 November 2017
Guido Tricot
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
12149193
retrieved
29 November 2017
publication date
1 August 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
12149193
retrieved
29 November 2017
page(s)
1168-1171
1 reference
stated in
Europe PubMed Central
PubMed ID
12149193
retrieved
29 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44083616&oldid=1410725651"